Gregory H. Turner1, Do-Young Kim1, Junwei Hao1, Ruolan Liu1, Jong M. Rho1, Fu-Dong Shi1
Dietary treatments have become increasingly used as an alternative therapy to address a variety of neurological disorders. The ketogenic diet (KD) has been shown to promise in both translational studies and in the clinic. For this study the effects of the KD on an experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis was investigated. In vivo MRI and bioluminescence imaging were used to examine lesion development and measure reactive oxygen species (ROS) in EAE mice given the KD. These studies revealed that the KD yields a reduction of the inflammatory response in an EAE model of multiple sclerosis.